rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
1988-9-13
|
pubmed:abstractText |
A rabbit model system is described. It allows accurate measurement of the dose-dependent loss of glycosaminoglycan from the nucleus pulposus of lumbar intervertebral discs after injection of a proteinase. At the dose equivalent to that of chymopapain used in human chemonucleolysis, two human serine proteinases, cathepsin G and chymotrypsin, were as effective as chymopapain in removing up to 80% of the glycosaminoglycan from the disc. A cysteine proteinase, cathepsin B released no more than 45% of glycosaminoglycan. X-ray films clearly showed narrowing of the disc space when 30-40% of glycosaminoglycan was removed. The degradation of the nucleus pulposus was seen histologically as loss of toluidine blue metachromasia.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0362-2436
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
13
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
188-92
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:3043717-Animals,
pubmed-meshheading:3043717-Cathepsin G,
pubmed-meshheading:3043717-Cathepsins,
pubmed-meshheading:3043717-Chymopapain,
pubmed-meshheading:3043717-Chymotrypsin,
pubmed-meshheading:3043717-Endopeptidases,
pubmed-meshheading:3043717-Glycosaminoglycans,
pubmed-meshheading:3043717-Humans,
pubmed-meshheading:3043717-Intervertebral Disc,
pubmed-meshheading:3043717-Intervertebral Disc Chemolysis,
pubmed-meshheading:3043717-Lumbar Vertebrae,
pubmed-meshheading:3043717-Serine Endopeptidases
|
pubmed:year |
1988
|
pubmed:articleTitle |
Quantitative assessment of human proteinases as agents for chemonucleolysis.
|
pubmed:affiliation |
Biochemistry Department, Strangeways Research Laboratory, Worts Causeway, Cambridge, United Kingdom.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|